|
Q2 2022
Filed on Aug 15, 2022
|
61,424
|
$3.6 - $11.2
$221K - $688K
|
|
|
Q2 2022
Filed on Aug 15, 2022
|
610,970
|
$21.74 - $46.75
$13.3M - $28.6M
|
|
|
Q2 2022
Filed on Aug 15, 2022
|
274,458
|
$10.71 - $18.33
$2.94M - $5.03M
|
|
|
Q2 2022
Filed on Aug 15, 2022
|
676,975
|
$75.79 - $100.07
$51.3M - $67.7M
|
|
|
Q2 2022
Filed on Aug 15, 2022
|
123,456
|
$62.69 - $88.44
$7.74M - $10.9M
|
|
|
Q2 2022
Filed on Aug 15, 2022
|
48,168
|
$36.28 - $75.29
$1.75M - $3.63M
|
|
Apellis Pharmaceuticals, Inc.
|
Q1 2022
Filed on May 16, 2022
|
31,754,000
|
N/A
|
|
|
Q1 2022
Filed on May 16, 2022
|
27,500,000
|
N/A
|
|
|
Q1 2022
Filed on May 16, 2022
|
610,626
|
$2.22 - $4.47
$1.36M - $2.73M
|
|
|
Q1 2022
Filed on May 16, 2022
|
104,521
|
$23.94 - $33.74
$2.5M - $3.53M
|
|
|
Q1 2022
Filed on May 16, 2022
|
2,697,110
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
520,523
|
$17.78 - $33.08
$9.25M - $17.2M
|
|
Bio Marin Pharmaceutical Inc.
|
Q4 2021
Filed on Feb 14, 2022
|
4,500,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
22,430
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
518,380
|
$9.44 - $12.24
$4.89M - $6.34M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1,406,037
|
$7.07 - $17.5
$9.94M - $24.6M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1,420,740
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
55,555
|
$6.96 - $9.25
$387K - $514K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
2,108,621
|
$3.14 - $3.9
$6.62M - $8.22M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1,192,003
|
$2.24 - $4.29
$2.67M - $5.11M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
65,497
|
$4.08 - $5.66
$267K - $371K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1,418,107
|
$20.45 - $30.0
$29M - $42.5M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
455,276
|
$12.95 - $49.69
$5.9M - $22.6M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
2,271,917
|
$31.4 - $69.84
$71.3M - $159M
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
133,833
|
$7.82 - $12.44
$1.05M - $1.66M
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
14,720
|
$3.8 - $4.63
$55.9K - $68.2K
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
11,180
|
$68.86 - $83.34
$770K - $932K
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
461,726
|
$4.78 - $7.96
$2.21M - $3.68M
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
2,047,180
|
$1.01 - $1.58
$2.07M - $3.23M
|
|
Alexion Pharmaceuticals, Inc.
|
Q2 2021
Filed on Aug 16, 2021
|
3,993,312
|
N/A
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
429,063
|
$10.17 - $12.64
$4.36M - $5.42M
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
138,040
|
$2.72 - $4.04
$375K - $558K
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
184,927
|
$2.24 - $3.9
$414K - $721K
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
363,980
|
$5.19 - $6.73
$1.89M - $2.45M
|
|
Adamas Pharmaceuticals, Inc.
|
Q2 2021
Filed on Aug 16, 2021
|
147,996
|
N/A
|
|
Constellation Pharmaceuticals, Inc.
|
Q2 2021
Filed on Aug 16, 2021
|
114,735
|
N/A
|
|
|
Q1 2021
Filed on May 17, 2021
|
111,296
|
$46.59 - $83.68
$5.19M - $9.31M
|
|
|
Q1 2021
Filed on May 17, 2021
|
955,690
|
$2.42 - $4.47
$2.31M - $4.27M
|
|
|
Q1 2021
Filed on May 17, 2021
|
522,360
|
$1.98 - $5.36
$1.03M - $2.8M
|
|
|
Q1 2021
Filed on May 17, 2021
|
480,729
|
$8.63 - $10.94
$4.15M - $5.26M
|
|
|
Q1 2021
Filed on May 17, 2021
|
72,709
|
$26.16 - $41.39
$1.9M - $3.01M
|
|
|
Q1 2021
Filed on May 17, 2021
|
1,398,795
|
$5.64 - $23.33
$7.89M - $32.6M
|
|
|
Q1 2021
Filed on May 17, 2021
|
379,682
|
$37.26 - $67.74
$14.1M - $25.7M
|
|
Dicerna Pharmaceuticals, Inc.
|
Q1 2021
Filed on May 17, 2021
|
102,121
|
N/A
|
|
Sunesis Pharmaceuticals, Inc.
|
Q1 2021
Filed on May 17, 2021
|
53,066
|
N/A
|
|
Five Prime Therapeutics, Inc.
|
Q1 2021
Filed on May 17, 2021
|
668,000
|
N/A
|
|
|
Q1 2021
Filed on May 17, 2021
|
112,897
|
N/A
|
|
|
Q1 2021
Filed on May 17, 2021
|
6,740
|
$29.24 - $42.03
$197K - $283K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
1,846,139
|
$99.61 - $142.12
$184M - $262M
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
3,009,344
|
N/A
|
|